Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1];  [2];  [1];  [1];  [1];  [1]
  1. Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health - NIH, Bethesda, MD 20892 (United States)
  2. Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD 20892 (United States)

Highlights: Black-Right-Pointing-Pointer MR contrast agents exert influence on T{sub 1} or T{sub 2} relaxation time of the surrounding tissue. Black-Right-Pointing-Pointer Combined use of iron oxide and Gd-DTPA can improve the sensitivity/specificity of lesion detection. Black-Right-Pointing-Pointer Dual contrast MRI enhances the delineation of tumor borders and small lesions. Black-Right-Pointing-Pointer The effect of DC-MRI can come from the high paramagnetic susceptibility of Gd{sup 3+}. Black-Right-Pointing-Pointer The effect of DC-MRI can also come from the distinct pharmacokinetic distribution of SPIO and Gd-DTPA. -- Abstract: Purpose: The use of MR contrast agents allows accurate diagnosis by exerting an influence on the longitudinal (T{sub 1}) or transverse (T{sub 2}) relaxation time of the surrounding tissue. In this study, we combined the use of iron oxide (IO) particles and nonspecific extracellular gadolinium chelate (Gd) in order to further improve the sensitivity and specificity of lesion detection. Procedures: With a 7-Tesla scanner, pre-contrasted, IO-enhanced and dual contrast agent enhanced MRIs were performed in phantom, normal animals, and animal models of lymph node tumor metastases and orthotopic brain tumor. For the dual-contrast (DC) MRI, we focused on the evaluation of T{sub 2} weighted DC MRI with IO administered first, then followed by the injection of a bolus of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Results: Based on the C/N ratios and MRI relaxometry, the synergistic effect of coordinated administration of Gd-DTPA and IO was observed and confirmed in phantom, normal liver and tumor models. At 30 min after administration of Feridex, Gd-DTPA further decreased T{sub 2} relaxation in liver immediately after the injection. Additional administration of Gd-DTPA also immediately increased the signal contrast between tumor and brain parenchyma and maximized the C/N ratio to -4.12 {+-} 0.71. Dual contrast MRI also enhanced the delineation of tumor borders and small lesions. Conclusions: DC-MRI will be helpful to improve diagnostic accuracy and decrease the threshold size for lesion detection.

OSTI ID:
22210238
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 4 Vol. 425; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English

Similar Records

A novel contrast agent with rare earth-doped up-conversion luminescence and Gd-DTPA magnetic resonance properties
Journal Article · Wed Aug 15 00:00:00 EDT 2012 · Journal of Solid State Chemistry · OSTI ID:22131103

Magnetic Resonance Imaging of Therapy-Induced Necrosis Using Gadolinium-Chelated Polyglutamic Acids
Journal Article · Sun Jul 01 00:00:00 EDT 2007 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20951712

Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA
Conference · Thu Feb 28 23:00:00 EST 1985 · Radiology; (United States) · OSTI ID:5650823